New Hope Rises on Strong Q3 Result
New Hope Corporation (ASX:NHC) shares pushed higher on Monday, testing intraday highs of A$5.32 after the coal miner delivered a strong Q3 FY26 result. Underlying EBITDA jumped 21.7% to A$130.1 million as the company sold more coal at slightly higher prices. While most investors have spent 2026 chasing…
NVIDIA (NASDAQ: NVDA) reports its latest quarterly numbers after the US market closes on Wednesday, 20 May, which is Thursday morning here in Australia. The world's most-watched chip company sells the powerful GPUs that companies like Microsoft, Amazon and Google use to run their artificial intelligence systems. Last quarter, NVIDIA's data centre business alone brought…
ALS Limited Falls Despite Record FY26 Profit
ALS Limited (ASX: ALQ) shares slipped 1.7% on Monday to close at A$21.83, even after the lab testing giant reported the strongest year in its history. Revenue climbed 10.7% to A$3.32 billion and underlying profit jumped 25.8% to A$381.2 million, with the company also paying down debt. So…
Pro Medicus Wins A$90m Beth Israel Lahey Deal
Pro Medicus (ASX:PME) has landed another major US contract, signing a seven-year, A$90m deal with Beth Israel Lahey Health, a Boston-based hospital network. The contract will see Pro Medicus roll out its cloud-based Visage 7 imaging platform across 14 hospitals in Massachusetts and New Hampshire, with the…
Tax Loss Selling Season Is Coming: 7 Beaten-Down ASX Stocks Most Likely to Get Dumped Before June 30
ASX Stocks Most Exposed Before June 30
Every June, billions of dollars get sold on the ASX for tax reasons rather than business reasons. With the Australian financial year ending June 30, investors are clearly losing positions to offset gains taken elsewhere. The pressure usually peaks in the final two weeks before EOFY, pushing already-weak…
Racura Oncology Surges on Trial Update
Racura Oncology (ASX: RAC) climbed 8.66 per cent on Friday to close at A$2.76, after the independent Safety Review Committee cleared the company to double the dosage level in its CPACS Phase 1 cancer trial. The first three patients in Cohort 1 showed no dose-limiting toxicities and remain alive…
ASX 200 Falls as Budget and DRO Hit Market
The S&P/ASX 200 closed Friday at 8,630.80, down 1.3% for the week and sitting at a five-week low. It was a choppy week pulled in three directions. The Federal Budget rewrote the rules on capital gains tax. DroneShield got hit with an ASIC probe. And on…
Federal Budget 2026 Changes Hit ASX Blue Chips
The Federal Budget delivered on 12 May 2026 included one of the most significant tax changes for Australian investors in over two decades. From 1 July 2027, the 50% capital gains tax discount that has applied since 1999 will be replaced by cost base indexation, paired with a…
Vicinity Centres Rises on Eastern Creek Deal
Vicinity Centres (ASX: VCX) shares jumped 1.62% to A$2.51 on Friday after the retail property giant announced a A$400 million deal to buy Eastern Creek Quarter (ECQ) from Frasers Property Australia. The site sits about 41 km from Sydney's CBD and packs more than 40,000 sqm of retail…
Electro Optic Systems Surges on MARSS Deal Update
Electro Optic Systems (ASX:EOS) climbed around 4.6% on Friday to A$8.86 after the company revised the terms of its MARSS acquisition and confirmed fresh Middle East defence contracts. The deal expansion lifts the earnout cap from €100 million to €140 million (around A$226 million), reflecting stronger confidence…
